vs
Side-by-side financial comparison of John Marshall Bancorp, Inc. (JMSB) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
John Marshall Bancorp, Inc. is the larger business by last-quarter revenue ($16.8M vs $13.2M, roughly 1.3× TriSalus Life Sciences, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs -73.9%, a 110.2% gap on every dollar of revenue. Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 15.3%).
John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
JMSB vs TLSI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.8M | $13.2M |
| Net Profit | $6.1M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | — | -24.8% |
| Net Margin | 36.3% | -73.9% |
| Revenue YoY | — | 59.8% |
| Net Profit YoY | 26.8% | 3.5% |
| EPS (diluted) | $0.43 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $16.8M | — | ||
| Q4 25 | $16.4M | $13.2M | ||
| Q3 25 | $16.3M | $11.6M | ||
| Q2 25 | $15.4M | $11.2M | ||
| Q1 25 | $14.6M | $9.2M | ||
| Q4 24 | $14.3M | $8.3M | ||
| Q3 24 | $13.8M | $7.3M | ||
| Q2 24 | $12.6M | $7.4M |
| Q1 26 | $6.1M | — | ||
| Q4 25 | $5.9M | $-9.8M | ||
| Q3 25 | $5.4M | $-10.8M | ||
| Q2 25 | $5.1M | $-8.3M | ||
| Q1 25 | $4.8M | $-10.4M | ||
| Q4 24 | $4.8M | $-10.1M | ||
| Q3 24 | $4.2M | $-2.4M | ||
| Q2 24 | $3.9M | $-4.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% |
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | -24.8% | ||
| Q3 25 | 42.2% | -77.9% | ||
| Q2 25 | 42.7% | -65.4% | ||
| Q1 25 | 42.4% | -79.9% | ||
| Q4 24 | 42.5% | -91.8% | ||
| Q3 24 | 38.8% | -118.9% | ||
| Q2 24 | 39.7% | -111.0% |
| Q1 26 | 36.3% | — | ||
| Q4 25 | 36.2% | -73.9% | ||
| Q3 25 | 33.2% | -93.5% | ||
| Q2 25 | 33.1% | -73.9% | ||
| Q1 25 | 32.9% | -113.2% | ||
| Q4 24 | 33.3% | -122.4% | ||
| Q3 24 | 30.7% | -32.6% | ||
| Q2 24 | 30.9% | -58.8% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.41 | $-0.22 | ||
| Q3 25 | $0.38 | $-0.96 | ||
| Q2 25 | $0.36 | $-0.27 | ||
| Q1 25 | $0.34 | $-0.39 | ||
| Q4 24 | $0.33 | $-0.38 | ||
| Q3 24 | $0.30 | $-0.12 | ||
| Q2 24 | $0.27 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $150.2M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $268.1M | $-33.9M |
| Total Assets | $2.4B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $150.2M | — | ||
| Q4 25 | $130.0M | $20.4M | ||
| Q3 25 | $163.6M | $22.7M | ||
| Q2 25 | $116.9M | $26.5M | ||
| Q1 25 | $169.1M | $13.0M | ||
| Q4 24 | $122.5M | $8.5M | ||
| Q3 24 | $177.2M | $11.3M | ||
| Q2 24 | $182.6M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $80.9M | — | ||
| Q3 25 | $80.9M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $80.8M | — | ||
| Q4 24 | $80.8M | — | ||
| Q3 24 | $80.8M | — | ||
| Q2 24 | $24.7M | — |
| Q1 26 | $268.1M | — | ||
| Q4 25 | $265.6M | $-33.9M | ||
| Q3 25 | $259.7M | $-26.7M | ||
| Q2 25 | $253.7M | $-19.4M | ||
| Q1 25 | $253.0M | $-34.4M | ||
| Q4 24 | $246.6M | $-25.9M | ||
| Q3 24 | $243.1M | $-20.4M | ||
| Q2 24 | $235.3M | $-25.3M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.3B | $35.3M | ||
| Q3 25 | $2.3B | $36.5M | ||
| Q2 25 | $2.3B | $41.3M | ||
| Q1 25 | $2.3B | $28.6M | ||
| Q4 24 | $2.2B | $24.0M | ||
| Q3 24 | $2.3B | $27.5M | ||
| Q2 24 | $2.3B | $32.4M |
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $22.6M | $-2.5M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $7.5M | $-7.3M | ||
| Q1 25 | $7.0M | $-4.5M | ||
| Q4 24 | $17.3M | $-5.7M | ||
| Q3 24 | $1.4M | $-10.8M | ||
| Q2 24 | $10.2M | $-13.4M |
| Q1 26 | — | — | ||
| Q4 25 | $22.0M | $-2.5M | ||
| Q3 25 | $1.2M | $-3.9M | ||
| Q2 25 | $7.4M | $-7.4M | ||
| Q1 25 | $6.6M | $-5.3M | ||
| Q4 24 | $16.8M | $-5.8M | ||
| Q3 24 | $1.3M | $-11.0M | ||
| Q2 24 | $10.1M | $-13.5M |
| Q1 26 | — | — | ||
| Q4 25 | 134.7% | -19.1% | ||
| Q3 25 | 7.3% | -33.9% | ||
| Q2 25 | 47.8% | -66.1% | ||
| Q1 25 | 45.3% | -57.3% | ||
| Q4 24 | 116.9% | -69.7% | ||
| Q3 24 | 9.5% | -149.9% | ||
| Q2 24 | 80.1% | -183.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 0.3% | ||
| Q3 25 | 0.2% | 1.9% | ||
| Q2 25 | 1.0% | 0.8% | ||
| Q1 25 | 2.3% | 8.2% | ||
| Q4 24 | 3.4% | 0.6% | ||
| Q3 24 | 0.8% | 2.3% | ||
| Q2 24 | 0.4% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 2.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JMSB
| Net Interest Income | $16.5M | 98% |
| Noninterest Income | $284.0K | 2% |
TLSI
Segment breakdown not available.
